Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 3195

1.

LPHN3 and Attention-Deficit/Hyperactivity Disorder: a susceptibility and pharmacogenetics study.

Bruxel EM, Salatino-Oliveira A, Akutagava-Martins GC, Tovo-Rodrigues L, Genro JP, Zeni CP, Polanczyk GV, Chazan R, Schmitz M, Arcos-Burgos M, Rohde LA, Hutz MH.

Genes Brain Behav. 2015 May 19. doi: 10.1111/gbb.12224. [Epub ahead of print]

PMID:
25989180
2.

Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO.

Mazzola E, Blackford A, Parmigiani G, Biswas S.

Cancer Inform. 2015 May 10;14(Suppl 2):147-57. doi: 10.4137/CIN.S17292. eCollection 2015. Review.

PMID:
25983549
4.

Effect of MTHFR, TGFβ1, and TNFB polymorphisms on osteoporosis in rheumatoid arthritis patients.

Saad MN, Mabrouk MS, Eldeib AM, Shaker OG.

Gene. 2015 May 14. pii: S0378-1119(15)00609-5. doi: 10.1016/j.gene.2015.05.037. [Epub ahead of print]

PMID:
25981594
5.

DNA Methylation and MicroRNA-Based Biomarkers for Risk of Type 2 Diabetes.

O'Connell TM, Markunas CA.

Curr Diabetes Rev. 2015 May 15. [Epub ahead of print]

PMID:
25981498
6.

Prediction of Heart Attack Risk Using GA-ANFIS Expert System Prototype.

Begic Fazlic L, Avdagic A, Besic I.

Stud Health Technol Inform. 2015;211:292-4.

PMID:
25980885
7.

A practical application of two in silico systems for identification of potentially mutagenic impurities.

Greene N, Dobo KL, Kenyon MO, Cheung J, Munzner J, Sobol Z, Sluggett G, Zelesky T, Sutter A, Wichard J.

Regul Toxicol Pharmacol. 2015 May 14. pii: S0273-2300(15)00107-5. doi: 10.1016/j.yrtph.2015.05.008. [Epub ahead of print]

PMID:
25980641
8.

Annotation of Sequence Variants in Cancer Samples: Processes and Pitfalls for Routine Assays in the Clinical Laboratory.

Lee LA, Arvai KJ, Jones D.

J Mol Diagn. 2015 May 11. pii: S1525-1578(15)00073-2. doi: 10.1016/j.jmoldx.2015.03.003. [Epub ahead of print] Review.

PMID:
25977238
9.

Genetics of diabetic nephropathy: a long road of discovery.

McKnight AJ, Duffy S, Maxwell AP.

Curr Diab Rep. 2015 Jul;15(7):610. doi: 10.1007/s11892-015-0610-9.

PMID:
25971618
10.

Prevalence of the UGT1A1*6 (c.211G>A) Polymorphism and Prediction of Irinotecan Toxicity in Iranian Populations of Different Ethnicities.

Shakibi R, Kamalidehghan B, Ahmadipour F, Meng GY, Houshmand M.

Chemotherapy. 2015 May 9;60(5):279-287. [Epub ahead of print]

PMID:
25967674
11.

Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer.

Wozniak MB, Scelo G, Muller DC, Mukeria A, Zaridze D, Brennan P.

PLoS One. 2015 May 12;10(5):e0125026. doi: 10.1371/journal.pone.0125026. eCollection 2015.

12.

Rheumatic heart disease in Africa: is there a role for genetic studies?

Mocumbi AO.

Cardiovasc J Afr. 2015 Mar-Apr;26(2 Suppl 1):S21-6. doi: 10.5830/CVJA-2015-037.

PMID:
25962944
13.

Rare and Coding Region Genetic Variants Associated With Risk of Ischemic Stroke: The NHLBI Exome Sequence Project.

Auer PL, Nalls M, Meschia JF, Worrall BB, Longstreth WT Jr, Seshadri S, Kooperberg C, Burger KM, Carlson CS, Carty CL, Chen WM, Cupples LA, DeStefano AL, Fornage M, Hardy J, Hsu L, Jackson RD, Jarvik GP, Kim DS, Lakshminarayan K, Lange LA, Manichaikul A, Quinlan AR, Singleton AB, Thornton TA, Nickerson DA, Peters U, Rich SS; National Heart, Lung, and Blood Institute Exome Sequencing Project.

JAMA Neurol. 2015 May 11. doi: 10.1001/jamaneurol.2015.0582. [Epub ahead of print]

PMID:
25961151
14.

Breast cancer risks and risk prediction models.

Engel C, Fischer C.

Breast Care (Basel). 2015 Feb;10(1):7-12. doi: 10.1159/000376600. Review.

PMID:
25960719
15.

Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: Recommendations of the innovative medicines initiative ABIRISK consortium.

Rup B, Pallardy M, Sikkema D, Albert T, Allez M, Broet P, Carini C, Creeke P, Davidson J, De Vries N, Finco D, Fogdell-Hahn A, Havrdova E, Hincelin-Mery A, Holland MC, Erik P, Jensen H, Jury EC, Kirby H, Kramer D, Lacroix-Desmazes S, Legrand J, Maggi E, Maillère B, Mariette X, Mauri C, Mikol V, Mulleman D, Oldenburg J, Paintaud G, Ross Pedersen C, Ruperto N, Seitz R, Spindeldreher S, Deisenhammer F; ABIRISK Consortium.

Clin Exp Immunol. 2015 May 8. doi: 10.1111/cei.12652. [Epub ahead of print]

PMID:
25959571
16.

A colorectal cancer prediction model using traditional and genetic risk scores in Koreans.

Jung KJ, Won D, Jeon C, Kim S, Kim TI, Jee SH, Beaty TH.

BMC Genet. 2015 May 9;16(1):49. doi: 10.1186/s12863-015-0207-y.

17.

Incremental predictive value of 152 single nucleotide polymorphisms in the 10-year risk prediction of incident coronary heart disease: the Rotterdam Study.

de Vries PS, Kavousi M, Ligthart S, Uitterlinden AG, Hofman A, Franco OH, Dehghan A.

Int J Epidemiol. 2015 May 6. pii: dyv070. [Epub ahead of print]

PMID:
25953786
18.

Emerging risk biomarkers in cardiovascular diseases and disorders.

Upadhyay RK.

J Lipids. 2015;2015:971453. doi: 10.1155/2015/971453. Epub 2015 Apr 8. Review.

19.

Polygenic risk scores in imaging genetics: Usefulness and applications.

Dima D, Breen G.

J Psychopharmacol. 2015 May 5. pii: 0269881115584470. [Epub ahead of print]

PMID:
25944849
20.

MHC-similarity and sexual selection: different doesn't always mean attractive.

Gasparini C, Congiu L, Pilastro A.

Mol Ecol. 2015 May 2. doi: 10.1111/mec.13222. [Epub ahead of print]

PMID:
25940673
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk